NanoBio Seals $11M Series C

NanoBio Corp. has closed an $11 million Series C financing from exiting investors, the company announced. Specifics of the round were not released. The infusion will go toward development of its products to treat conditions including cystic fibrosis, and for its nanoemulsion-based vaccines for respiratory syncytial virus.

North AmericaUSBriefs